2017
DOI: 10.1080/20009666.2017.1370940
|View full text |Cite
|
Sign up to set email alerts
|

An unusual case of chronic lymphocytic leukemia, multiple myeloma and cardiac amyloidosis

Abstract: Light chain amyloidosis has very rarely been reported in association with chronic lymphocytic leukemia (CLL). We reported on a 76-years-old female who presented with simultaneous kappa-restricted chronic lymphocytic leukemia (CLL) and a lambda-restricted multiple myeloma with plasma cells causing AL amyloidosis involving the heart. While monoclonal immunoglobulins occasionallyproduced by CLL have previously been implicated in AL amyloidosis, there only a few cases reported of AL amyloidosis resulting from a di… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 12 publications
(13 reference statements)
0
2
0
Order By: Relevance
“…AL is a systemic disorder characterized by widespread deposition of amyloid fibrils derived from monoclonal immunoglobulin light chains in organs and soft tissues. AL is typically caused by an underlying plasma cell clone disorder and occurs in 6–15% of patients with MM [13] .…”
Section: Discussionmentioning
confidence: 99%
“…AL is a systemic disorder characterized by widespread deposition of amyloid fibrils derived from monoclonal immunoglobulin light chains in organs and soft tissues. AL is typically caused by an underlying plasma cell clone disorder and occurs in 6–15% of patients with MM [13] .…”
Section: Discussionmentioning
confidence: 99%
“…Multiple potential mechanisms have been suggested including leucocyte aggregation and adhesion with vessel plugging, activation of the coagulation system, interaction with platelets to promote thrombin generation, increased expression of monocyte and neutrophil tissue factors, and release of soluble mediators such as proteases, reactive oxygen species, growth factors, interleukins, and myeloperoxidase [ 16 18 ]. Patients with CLL may also develop amyloid infiltration of the heart, either paraprotein-related AL amyloid [ 19 ] or, less commonly, non-AL; the latter group appears to have a better prognosis [ 20 ]. Amyloid can also deposit within vessels causing occlusion [ 21 ].…”
Section: Discussionmentioning
confidence: 99%